Activity of chemotherapy in mucinous epithelial ovarian cancer: A retrospective study

Carmela Pisano, Stefano Greggi, Rosa Tambaro, Simona Losito, Francesco Iodice, Massimo Di Maio, Ettore Ferrari, Marzia Falanga, Roberta Formato, Vincenzo Rosario Iaffaioli, Sandro Pignata

Research output: Contribution to journalArticlepeer-review


Objective: Mucinous ovarian carcinoma has a poorer prognosis compared with other histological subtypes. The aim of this study was to evaluate, retrospectively, the activity of first-line and second-line chemotherapy in patients with mutinous ovarian cancer in a mono-institutional series. Patients and Methods: In the period under survey (1996-2003), 225 new patients with ovarian cancer were treated. Twenty-one out of these patients (9.3%) received a diagnosis of mucinous ovarian cancer. The median age, performance status, stage at diagnosis and residual disease after surgery were similar in the mucinous compared to the other histological groups (P=NS). Results: In mucinous ovarian cancer the grading of the tumors was 2 in 76% of the cases, while grade 3 was more frequent in the other subtypes (p

Original languageEnglish
Pages (from-to)3501-3505
Number of pages5
JournalAnticancer Research
Issue number5
Publication statusPublished - Sep 2005


  • Chemotherapy
  • Mucinous
  • Ovarian cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'Activity of chemotherapy in mucinous epithelial ovarian cancer: A retrospective study'. Together they form a unique fingerprint.

Cite this